PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8+ T cell Induced Death

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8+ T cell Induced Death ; volume:9 ; number:1 ; day:17 ; month:1 ; year:2019 ; pages:1-14 ; date:12.2019
Scientific reports ; 9, Heft 1 (17.1.2019), 1-14, 12.2019

Classification: Naturwissenschaften

Creator: Suarez, Guadalupe Verónica
Melucci Ganzarain, Claudia del Carmen
Vecchione, María Belén
Trifone, César Ariel
Marín Franco, José Luis
Genoula, Melanie
Moraña, Eduardo José
Balboa, Luciana
Quiroga, Maria Florencia

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-018-36403-2

URN: urn:nbn:de:101:1-2019021316212317360613

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Suarez, Guadalupe Verónica
Melucci Ganzarain, Claudia del Carmen
Vecchione, María Belén
Trifone, César Ariel
Marín Franco, José Luis
Genoula, Melanie
Moraña, Eduardo José
Balboa, Luciana
Quiroga, Maria Florencia
SpringerLink (Online service)

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

PD-L1 Expression und CD8 positive zytotoxische Lymphozyten in mesenchymalen Tumoren

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

PD-L1 Expression und CD8 positive zytotoxische Lymphozyten in mesenchymalen Tumoren

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

PD-L1 Expression und CD8 positive zytotoxische Lymphozyten in mesenchymalen Tumoren

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8+ T cell Induced Death

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

PD-L1 Expression und CD8 positive zytotoxische Lymphozyten in mesenchymalen Tumoren

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

PD-L1 Expression und CD8 positive zytotoxische Lymphozyten in mesenchymalen Tumoren

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

PD-L1 Expression und CD8 positive zytotoxische Lymphozyten in mesenchymalen Tumoren

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

Related objects

Reset password